Sweeny Nicole

CIK 00018275052 companiesFRAMINGHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001827505

Recent Transactions

28 trades

Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-23$15.57/sh−3,975→ 47,003 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-02-22−5,000→ 45,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-22+5,000→ 50,978 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-21+6,250→ 45,978 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-02-21−6,250→ 75,000 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-01-16+100,000→ 100,000 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−3,813→ 39,728 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-22+5,000→ 43,541 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-22−5,000→ 50,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+6,250→ 38,541 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−6,250→ 81,250 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-25$13.42/sh−1,480→ 32,291 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-22−5,000→ 55,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-22+5,000→ 33,771 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-22$13.22/sh−1,864→ 28,771 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-21+6,250→ 30,635 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-21−6,250→ 87,500 total
Tax Payment
Praxis Precision Medicines, Inc.$PRAX
Common Stock
2023-02-12$3.94/sh−1,456→ 38,619 total
Award
Praxis Precision Medicines, Inc.$PRAX
Stock Option (Right to Buy)
2023-01-12+41,085→ 41,085 total
Award
Praxis Precision Medicines, Inc.$PRAX
Stock Option (Right to Buy)
2023-01-12+120,000→ 120,000 total
Tax Payment
Praxis Precision Medicines, Inc.$PRAX
Common Stock
2023-01-07$2.52/sh−2,079→ 40,075 total
Award
Praxis Precision Medicines, Inc.$PRAX
Stock Option (Right to Buy)
2022-06-22+65,000→ 65,000 total
Award
Praxis Precision Medicines, Inc.$PRAX
Common Stock
2022-05-13$8.80/sh+2,587→ 42,154 total
Tax Payment
Praxis Precision Medicines, Inc.$PRAX
Common Stock
2022-02-12$12.85/sh−1,233→ 39,567 total
Award
Praxis Precision Medicines, Inc.$PRAX
Stock Option (Right to Buy)
2022-01-07+84,000→ 84,000 total
Award
Praxis Precision Medicines, Inc.$PRAX
Common Stock
2022-01-07+24,000→ 40,800 total
Award
Praxis Precision Medicines, Inc.$PRAX
Stock Option (Right to Buy)
2021-02-12+58,880→ 58,880 total
Award
Praxis Precision Medicines, Inc.$PRAX
Common Stock
2021-02-12+16,800→ 16,800 total

Companies

Recent Filings

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702

View on SEC.gov